Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
4d
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Guidehouse, a global consultancy providing advisory, digital, and managed services to the commercial and public sectors, has teamed up with the Healthcare Information and Management Systems Society ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
The medical field constantly changes, providing numerous opportunities for professionals to enhance their skills and ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...
WOBURN, MA, UNITED STATES, February 12, 2025 /EINPresswire / -- ScribeEMR, a leading provider of AI-powered healthcare documentation solution ...
Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
The HIMSS Mission is to reform the global health ... the field of Applied Medical Informatics and thereby improving the practice of medicine. AMDIS is the home for the connected CMIO.
Healthcare is no stranger to managed service providers, as many health systems depend on temporary clinical staff, legal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results